Tatva Chintan Pharma Chem Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tatva Chintan Pharma Chem Limited generated cash of $980,440,000, which is more than the previous year. Cash used in financing activities reached the amount of $305,190,000 last year. Net change in cash is therefore $79,390,000.
Cash Flow
| 2018 | 104.12M | -303.92M | 97.44M |
|---|---|---|---|
| 2020 | 253.12M | -401.8M | 99.52M |
| 2021 | 243.19M | -210.06M | -88.01M |
| 2023 | 277.83M | -1.01B | 377.95M |
| 2024 | 980.44M | -1.20B | 305.19M |
TATVA.NS Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|
Cash at beginning of period | 273.65M | 630.17M | 108.29M | 157.45M | 0 |
Operating activities | |||||
Net income | 303.54M | 447.79M | 606.96M | 475.97M | 122.89M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 256.05M | 95.55M | 67.32M | 47.93M | 29.52M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 153.85M | -314.4M | -419.3M | -83.13M | -84.06M |
Inventories | 97.32M | 74.59M | -84.63M | -279.64M | -29.78M |
Accounts payable | 112.48M | -126.56M | 158.64M | 94.77M | 63.19M |
Cash generated by operating activities | 980.44M | 277.83M | 243.19M | 253.12M | 104.12M |
Investing activities | |||||
Purchases Of Investments | -99M | -967.42M | -190K | -270K | 0 |
Investments In Property Plant And Equipment | -1.28B | -2.03B | -209.7M | -481.72M | -304.61M |
Acquisitions Net | 0 | 680K | 190K | 270K | 610K |
Cash generated by investing activities | -1.20B | -1.01B | -210.06M | -401.8M | -303.92M |
Financing activities | |||||
Common Stock Issued | 12.27M | 0 | 0 | 0 | 0 |
Payments for dividends | -46.78M | -44.33M | -40.18M | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.54B | 506.32M | -183.99M | 135.41M | 97.64M |
Cash used in financing activities | 305.19M | 377.95M | -88.01M | 99.52M | 97.44M |
Net Change In Cash | 79.39M | -356.51M | -54.88M | -49.16M | 77.6M |
Cash at end of period | 353.04M | 273.66M | 53.41M | 108.29M | 77.6M |
| Data source | Data source | Data source | Data source | Data source |